Dominic R. Cundari
Chief Commercial Officer, DiaMedica Therapeutics Inc.
Companies
- DiaMedica Therapeutics Inc.Chief Commercial Officer Feb 2, 2022 to Jun 3, 20241
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- DiaMedica Therapeutics Inc. DMAC2,800 shares2$22.3K at $7.96Jun 3, 2024
As of each latest filing. The line shows shares held over time.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2